Lein-Ray MO

Lein-Ray MO

Taiwan

Vice President

Show-Chwan Health Care System

Dr. Mo graduated from the National Taiwan University Medical College in June 1978. Following the completion of his military service, he pursued his residency and fellowship training at the National Taiwan University Hospital. Subsequently, he held the position of Chief in Internal Medicine and Gastroenterology at Show-Chwan Memorial Hospital. In 1989, he transitioned to Tainan Municipal Hospital, the first government-owned and privately managed hospital in Taiwan under the Show-Chwan healthcare system, where he served as President and continues the clinical research till now. Dr. Mo's research interests lie primarily in hepatology and gastroenterology, with a particular focus on interventional treatments for diseases such as Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma (HCC) and endoscopic management of biliary disorders. He has a distinguished record of academic achievement, having authored over 100 peer-reviewed publications in these fields, many of which appear in prestigious SCI journals. Currently, Dr. Mo serves as Vice President of the Show-Chwan healthcare system while maintaining his role at Tainan Municipal Hospital.

 Hepatology  Gastroenterology

 Master, School of Public Health, Tulane University U.S.A, 2007~2010  Bachelor in Medical College, National Taiwan University, Taipei Taiwan, 1971-1977

 The application of contrast-enhanced ultrasound for the characterization of hepatic tumors: An assessment focusing on hepatocellular carcinoma Adv. Dig Med.2019;6:15–20  Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. Asian Pac J Cancer Prev 2015;16(9):3595-604  The Optimal Timing for Using Capsule Endoscopy for Patients with Gastrointestinal Bleeding. Biomed Res Int. 2021 Mar 27;2021  Circumferential balloon-based radiofrequency ablation for ultralong and extensive flat esophageal squamous neoplasia. Gastrointest Endosc 2014 Dec;80(6):1185-9.  Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. J Hepatol 2013 Apr;58(4):730-5